v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities    
Net income $ 241,319 $ 247,803
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation 22,654 19,804
Amortization 4,543 4,312
Share-based compensation 17,475 12,950
Equity in loss (earnings) of unconsolidated investments, net 7 (41)
Other 732 (942)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Receivables (292,227) (254,322)
Product inventories 72,454 (29,375)
Prepaid expenses and other assets 25,560 53,440
Accounts payable (170,516) 315
Accrued expenses and other liabilities 77,251 (55,488)
Net cash used in operating activities (748) (1,544)
Investing activities    
Purchases of property and equipment, net of sale proceeds (36,569) (27,390)
Other investments, net 554 (1,073)
Net cash used in investing activities (36,015) (28,463)
Financing activities    
Proceeds from revolving line of credit 1,023,500 1,117,100
Payments on revolving line of credit (1,024,200) (956,900)
Payments on term loan under credit facility 0 (12,500)
Proceeds from asset-backed financing 308,900 323,200
Payments on asset-backed financing (167,900) (177,200)
Payments on term facility 0 (19,937)
Proceeds from short-term borrowings and current portion of long-term debt 6,577 17,112
Payments on short-term borrowings and current portion of long-term debt (6,163) (11,699)
Payments of excise tax on repurchases of common stock (2,974) 0
Proceeds from stock issued under share-based compensation plans 3,874 6,780
Payments of cash dividends (93,004) (92,163)
Repurchases of common stock (86,428) (160,648)
Net cash (used in) provided by financing activities (37,818) 33,145
Effect of exchange rate changes on cash and cash equivalents (1,620) 2,669
Change in cash and cash equivalents (76,201) 5,807
Cash and cash equivalents at beginning of period 104,963 77,862
Cash and cash equivalents at end of period $ 28,762 $ 83,669